pentobarbital will reduce the extent or influence of pitolisant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Pitolisant publicity is decreased by 50% if coadministered with powerful CYP3A4 inducers. Reserve concomitant prescribing of such drugs in pa